| Bio Roundup: A Royal IPO, Akili Arrives, Orca Bio Surfaces & More | Frank Vinluan | 06/19/20 | National |
| Agile Therapeutics Wins FDA Nod for Twirla Contraceptive Patch | Frank Vinluan | 02/14/20 | New York |
| Biotech Roundup: Gottlieb v. Juul, Solid Slumps, Avidity Gets $100M & More | Sarah de Crescenzo | 11/15/19 | National |
| Drug Pricing: Innovation, Investment, and the Public Good | Johannes Fruehauf | 09/24/19 | Boston |
| Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More | Frank Vinluan | 08/02/19 | National |
| Upjohn & Mylan to Merge, Freeing Pfizer to Focus on Biopharma R&D | Frank Vinluan | 07/29/19 | New York |
| Biogen, Taking Its Crisis “Seriously,” Keeps Focus on Neuroscience | Ben Fidler | 04/24/19 | Boston |
| Acorda Gets FDA Nod for New Parkinson’s Drug, But Rival Looms | Ben Fidler | 12/24/18 | New York |
| Bio Roundup: EpiPen Shortage, Bluebird’s Bet, Biotech IPOs & More | Frank Vinluan | 08/24/18 | National |
| Bio Roundup: Dunsire’s Danish, Price Hikes, Rare-Disease Race & More | Alex Lash | 07/06/18 | National |
| Bio Roundup: Not-BIO Party Foul, CRISPR Drama, Sickle Cell Updates | Ben Fidler | 06/15/18 | National |
| Report: Martin Shkreli Faces Prison Term After Fraud Conviction | Alex Lash | 08/04/17 | New York |
| Bio Roundup: Drug Pricing, Cystic Fibrosis Showdown, Myovant & More | Ben Fidler | 10/28/16 | National |
| How Doctors Think About Drug Prices | Alex Harding | 10/11/16 | Boston |
| Bio Roundup: Theranos Cuts, Alnylam Stops, Nobel Eats Its Own & More | Alex Lash | 10/07/16 | National |
| Bio Execs Talk Patient Advocacy, Duchenne Approval at BioForward Panel | Jeff Buchanan | 09/28/16 | Wisconsin |
| Bio Roundup: Mylan Grilled, Duchenne Kids Thrilled, Zuck-Chan & More | Alex Lash | 09/23/16 | National |
| Pharmaceutical Price Controls Might Be Closer Than You Think | Standish Fleming | 09/20/16 | San Diego |
| Bio Roundup: Mylan’s Shock, Hillary’s 3%, Duchenne Lessons & More | Ben Fidler | 08/26/16 | National |
| “Voice for Everyone”—Life-Sci Women Talk Venture, Pharma Gender Gap | Alex Lash | 03/04/15 | San Francisco |
| Pernix Buyout Ends Generic Nightmare for Sleeping Pill Maker Somaxon | Bruce V. Bigelow | 12/12/12 | San Diego |
| Somaxon Fighting Fresh Challenge from Generic Drug-Makers | Bruce V. Bigelow | 06/01/11 | San Diego |
